Skip to main content
Erschienen in: Inflammation 5/2023

13.06.2023 | RESEARCH

Interleukin-22 Inhibits Apoptosis of Gingival Epithelial Cells Through TGF-β Signaling Pathway During Periodontitis

verfasst von: Yina Huang, Lu Zhang, Lingping Tan, Chi Zhang, Xiting Li, Panpan Wang, Li Gao, Chuanjiang Zhao

Erschienen in: Inflammation | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Periodontitis is a chronic inflammatory disease characterized by the destruction of tooth-supporting tissues. The gingival epithelium is the first barrier of periodontal tissue against oral pathogens and harmful substances. The structure and function of epithelial lining are essential for maintaining the integrity of the epithelial barrier. Abnormal apoptosis can lead to the decrease of functional keratinocytes and break homeostasis in gingival epithelium. Interleukin-22 is a cytokine that plays an important role in epithelial homeostasis in intestinal epithelium, inducing proliferation and inhibiting apoptosis, but its role in gingival epithelium is poorly understood. In this study, we investigated the effect of interleukin-22 on apoptosis of gingival epithelial cells during periodontitis. Interleukin-22 topical injection and Il22 gene knockout were performed in experimental periodontitis mice. Human gingival epithelial cells were co-cultured with Porphyromonas gingivalis with interleukin-22 treatment. We found that interleukin-22 inhibited apoptosis of gingival epithelial cells during periodontitis in vivo and in vitro, decreasing Bax expression and increasing Bcl-xL expression. As for the underlying mechanisms, we found that interleukin-22 reduced the expression of TGF-β receptor type II and inhibited the phosphorylation of Smad2 in gingival epithelial cells during periodontitis. Blockage of TGF-β receptors attenuated apoptosis induced by Porphyromonas gingivalis and increased Bcl-xL expression stimulated by interleukin-22. These results confirmed the inhibitory effect of interleukin-22 on apoptosis of gingival epithelial cells and revealed the involvement of TGF-β signaling pathway in gingival epithelial cell apoptosis during periodontitis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
14.
Zurück zum Zitat Kotenko, S.V., L.S. Izotova, O.V. Mirochnitchenko, et al. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: The IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276: 2725–2732. https://doi.org/10.1074/jbc.M007837200.CrossRefPubMed Kotenko, S.V., L.S. Izotova, O.V. Mirochnitchenko, et al. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: The IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276: 2725–2732. https://​doi.​org/​10.​1074/​jbc.​M007837200.CrossRefPubMed
34.
Zurück zum Zitat Inaba, H., A. Amano, R. J. Lamont, et al. 2018. Cell cycle arrest and apoptosis induced by Porphyromonas gingivalis require Jun N-terminal protein kinase- and p53-mediated p38 activation in human trophoblasts. Infection and Immunity 86: e00923-17. https://doi.org/10.1128/iai.00923-17. Inaba, H., A. Amano, R. J. Lamont, et al. 2018. Cell cycle arrest and apoptosis induced by Porphyromonas gingivalis require Jun N-terminal protein kinase- and p53-mediated p38 activation in human trophoblasts. Infection and Immunity 86: e00923-17. https://​doi.​org/​10.​1128/​iai.​00923-17.
45.
Zurück zum Zitat Takahashi, J., M. Yamamoto, H. Yasukawa, et al. 2020. Interleukin-22 directly activates myocardial stat3 (signal transducer and activator of transcription-3) signaling pathway and prevents myocardial ischemia reperfusion injury. Journal of the American Heart Association 9: e014814. https://doi.org/10.1161/JAHA.119.014814. Takahashi, J., M. Yamamoto, H. Yasukawa, et al. 2020. Interleukin-22 directly activates myocardial stat3 (signal transducer and activator of transcription-3) signaling pathway and prevents myocardial ischemia reperfusion injury. Journal of the American Heart Association 9: e014814. https://​doi.​org/​10.​1161/​JAHA.​119.​014814.
52.
Zurück zum Zitat Dong, Y., C. Hu, C. Huang, et al. 2021. Interleukin-22 plays a protective role by regulating the JAK2-STAT3 pathway to improve inflammation, oxidative stress, and neuronal apoptosis following cerebral ischemia-reperfusion injury. Mediators of Inflammation 2021: 6621296. https://doi.org/10.1155/2021/6621296. Dong, Y., C. Hu, C. Huang, et al. 2021. Interleukin-22 plays a protective role by regulating the JAK2-STAT3 pathway to improve inflammation, oxidative stress, and neuronal apoptosis following cerebral ischemia-reperfusion injury. Mediators of Inflammation 2021: 6621296. https://​doi.​org/​10.​1155/​2021/​6621296.
54.
Zurück zum Zitat Bohn, S., L. Hexemer, Z. Huang, et al. 2023. State- and stimulus-specific dynamics of SMAD signaling determine fate decisions in individual cells. Proceedings of the National Academy of Sciences of the United States of America 120: e2210891120. https://doi.org/10.1073/pnas.2210891120. Bohn, S., L. Hexemer, Z. Huang, et al. 2023. State- and stimulus-specific dynamics of SMAD signaling determine fate decisions in individual cells. Proceedings of the National Academy of Sciences of the United States of America 120: e2210891120. https://​doi.​org/​10.​1073/​pnas.​2210891120.
61.
Zurück zum Zitat Nicolas, F.J., K. Lehmann, P.H. Warne, et al. 2003. Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest. Journal of Biological Chemistry 278: 3251–3256. https://doi.org/10.1074/jbc.M209019200.CrossRefPubMed Nicolas, F.J., K. Lehmann, P.H. Warne, et al. 2003. Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest. Journal of Biological Chemistry 278: 3251–3256. https://​doi.​org/​10.​1074/​jbc.​M209019200.CrossRefPubMed
Metadaten
Titel
Interleukin-22 Inhibits Apoptosis of Gingival Epithelial Cells Through TGF-β Signaling Pathway During Periodontitis
verfasst von
Yina Huang
Lu Zhang
Lingping Tan
Chi Zhang
Xiting Li
Panpan Wang
Li Gao
Chuanjiang Zhao
Publikationsdatum
13.06.2023
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01847-w

Weitere Artikel der Ausgabe 5/2023

Inflammation 5/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.